# Once Daily In-situ Forming Versus Twice-daily Conventional Metronidazole Vaginal Gels for Treatment of Bacterial Vaginosis

> **NCT02365389** · PHASE2,PHASE3 · COMPLETED · sponsor: **Assiut University** · enrollment: 64 (actual)

## Conditions studied

- Vaginitis

## Interventions

- **DRUG:** MTZ vaginal gel
- **DRUG:** Conventional MTZ vaginal gel

## Key facts

- **NCT ID:** NCT02365389
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2014-10
- **Final completion:** 2014-12
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2015-02-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02365389

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02365389, "Once Daily In-situ Forming Versus Twice-daily Conventional Metronidazole Vaginal Gels for Treatment of Bacterial Vaginosis". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02365389. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*